Objectives: Cardiac arrest etiology may be an important source of between-patient heterogeneity, but the impact of etiology on organ injury is unknown. We tested the hypothesis that asphyxial cardiac arrest results in greater neurologic injury than cardiac etiology cardiac arrest (ventricular fibrillation cardiac arrest), whereas ventricular fibrillation cardiac arrest results in greater cardiovascular dysfunction after return of spontaneous circulation. Design: Prospective observational human and randomized animal study.
A lmost 500,000 adult patients experience cardiac arrest (CA) in the United States annually (1) . Postresuscitation care guidelines are independent of etiology (2, 3) . Differences in clinical outcomes based on the presenting rhythm have been reported with shockable rhythms (ventricular fibrillation [VF] and pulseless ventricular tachycardia) having the best outcomes (4) (5) (6) (7) (8) . But, rhythm only loosely corresponds to etiology. The proportion of CA due to asphyxia (A-CA) has steadily increased associated with poor clinical outcomes (9-11) perhaps due to periarrest differences in physiology (12) , which may result in more severe neurologic injury driving worsened outcomes (7, 13) .
Animal models have yielded inconsistent results regarding heart and brain injury severity based on etiology (14, 15) . We previously demonstrated more severe histologic brain injury and cerebral blood flow (CBF) alterations induced by A-CA compared with VF of matched duration (16, 17) . Since CBF and systemic acidosis are determined by hemodynamics, heart and brain outcomes are inextricably linked. Our objective was a simultaneous characterization of both organ injury effects within an animal model controlling for factors such as ischemic time and cardiopulmonary resuscitation (CPR) quality supplemented by clinical observational findings. The goal was to better define the impact of CA etiology on heart and brain injury which drive clinical outcome (18, 19) . We hypothesized that A-CA results in greater neurologic impairment, whereas VF-CA results in greater hemodynamic impairment after return of spontaneous circulation (ROSC). Mechanistically, we hypothesized that these differences resulted from organspecific mitochondrial injury and/or oxidant stress.
MATERIALS AND METHODS
All animal experiments were approved by the Institutional Animal Care and Use Committee, and human research was approved by the Institutional Review Board of the University of Pittsburgh. Additional methods are listed in Supplemental Materials and Methods (Supplement Digital Content 1, http://links.lww.com/CCM/D384).
Rat CA Models
Adult male Sprague-Dawley rats were anesthetized with isoflurane, intubated and mechanically ventilated during surgical procedures. Electrocardiogram, respiratory rate, and arterial and venous pressure via fluid-filled catheters were continuously monitored. Rectal temperature was clamped at 37.0°C ± 0.5°C. VF and A-CA models are summarized in Supplemental Figure 1 (Supplemental Digital Content 2, http://links. lww.com/CCM/D385; legend, Supplemental Digital Content 7, http://links.lww.com/CCM/D390). VF was electrically induced over a period of 120 seconds and left untreated for 3 additional minutes (5 min no flow). Asphyxia was induced by neuromuscular blockade and ventilator disconnection resulting in a pulseless electrical activity (PEA) for 5 minutes. After 5 minutes of untreated VF/PEA, CPR was initiated by giving IV epinephrine and bicarbonate, resuming mechanical ventilation and initiating manual chest compressions. VF animals received defibrillation 60 seconds after CPR start with a second epinephrine dose given at 90 seconds before a second shock. Shocks were then repeated every 30 seconds if necessary up to 5 minutes after CPR start. After ROSC, all care was standardized. Sham rats underwent surgery but no CA.
Heart and Brain Injury Endpoints
Cardiac output (CO) was measured for 30 minutes using an ultrasonic flow probe. Neurologic Deficit Score (NDS) was obtained on postarrest days 1, 2, 3, and 8 as previously described: higher NDS indicates greater injury (20) . On days 7 and 8, a 2-day fear conditioning protocol (21) was employed to quantify cue-mediated freezing with greater freezing indicative of retained memory. Brain injury based on histology using hematoxylin and eosin (H&E) staining and Fluro-Jade B (FJB) staining was quantified by a blinded neuropathologist. Proportion of surviving hippocampal Cornu Ammonis region 1 (CA1) neurons (H&E) and neuropathologic scoring of other brain regions (FJB) are reported from 0 (no degeneration) to 5 (marked).
Mechanistic Endpoints
Brain mitochondria were isolated using a Percoll gradient (22) and heart mitochondria isolated by differential centrifugation (23) . States 2 and 3 mitochondrial respiration rates based on oxygen consumption were quantified using a Clark electrode and normalized to protein content. Respiratory control ratio was calculated as state 3:2 ratio. Ascorbate (22, 24) and antioxidant reserve (25) were assessed as previously described using whole brain homogenate.
Human CA Population
We validated our experimental findings using the University of Pittsburgh Post-Cardiac Arrest Service (PCAS) registry (19, 26, 27) including in-hospital and out-of-hospital CA patients. Our survival to hospital discharge exceeds 40%, and greater than 50% of survivors have functionally favorable outcome defined as discharge to home or acute inpatient rehabilitation (28) . CA etiology was assigned by structured chart review in 1,007 subjects (February 2, 2012, to February 2, 2016). Etiology was defined as "cardiac" (VF-CA) or "respiratory" (A-CA) as described in Supplemental Appendix 1 (Supplemental Digital Content 3, http://links.lww.com/CCM/D386). A random subset of 15% of etiologies was independently assigned by two reviewers to verify high interrater reliability.
Human CA Injury and Outcome Definitions
We prospectively categorize post-CA injury severity using the Pittsburgh Cardiac Arrest Category (PCAC), a validated four-point scale based on best neurologic and cardiopulmonary function within 6 hours of ROSC (19, 29) . PCAC I patients follow commands (best outcome), whereas PCAC IV patients are comatose with some brainstem reflex loss (worst outcome). PCAC is predictive of discharge (19, 27) and longterm CA outcome (30) . PCAC III have greater cardiopulmonary failure than PCAC II patients (29, 31) . Cardiac injury was quantified based on left ventricular ejection fraction (LVEF) on echocardiogram and peak troponin I within 3 days post arrest. In logistic models, these were dichotomized: LVEF, less than 35% versus greater than or equal to 35% (32), troponin, greater than or equal to 4.66 ng/mL versus less than 4.66 ng/mL (33) . Our primary marker of favorable neurologic/functional outcome was discharge to home or inpatient rehabilitation (28) , which predicts long-term survival (30) . Clinical covariates of age, gender, initial arrest rhythm, and arrest location (in hospital vs out of hospital) were obtained for model adjustment. We compared cause of death classified as "neurologic" or "cardiovascular" by the PCAS physician, with other causes excluded (Supplemental Materials and Methods, Supplement Digital Content 1, http://links.lww.com/CCM/D384).
Statistics
We report data as mean ± sd or median and interquartile range. Statistical analysis used Stata V.14.2 (StataCorp, College Station, TX). We compared categorical variables across arrest etiologies using chi-square or Fisher exact tests and compared continuous variables using t tests or RankSum tests as appropriate. We built logistic regression models to test the association of CA etiology with binary outcomes (LVEF and peak troponin) adjusting for clinical covariates and used ordered logistic regression to test the association between etiology and neurologic injury (PCAC I vs II/III vs IV). Cause of death based on etiology was compared using Fisher exact test.
RESULTS

Organ Injury After
Experimental CA Rats (n = 25) weighed 293 ± 18 g and were similar at baseline in terms of CO, pH, gas exchange, and hemodynamics (Supplemental Table 1 , Supplement Digital Content 3, http://links.lww.com/CCM/ D386). PEA occurred 154 ± 34 seconds after tracheal tube disconnection. CPR time to ROSC was longer for rats undergoing VF-CA (107 ± 24 s) compared with A-CA (50 ± 11 s; p ≤ 0.001). All 20 CA animals survived 30 minutes after ROSC. CO was significantly lower following VF-CA versus A-CA at 5 minutes (20 ± 10 vs 45 ± 9 mL/min) and during the entire 30-minute period of observation (Fig. 1A) (p = 0.01). We observed greater metabolic acidosis after VF-CA versus A-CA (pH 7.09 ± 0.04 vs 7.12 ± 0.04; all p < 0.001) (Fig. 1, B and C) . Differences between VF-CA and A-CA were maximal 5 minutes after ROSC (RO5; Supplemental Table 1 , Supplement Digital Content 3, http://links.lww.com/CCM/ D386) and included lower heart rate (237 ± 28 vs 321 ± 57 beats/min) and mean arterial pressure (54 ± 21 vs 84 ± 29 mm Hg) in VF-CA versus A-CA (Fig. 1, D and E) .
Separately, 25 rats were randomized to VF-CA (n = 10), A-CA (n = 10), or sham (n = 5) and survived 8 days post injury to assess neurologic injury. Two rats in the VF-CA group died because ROSC was not sustained. Neurologic disability quantified by NDS was worse after A-CA versus VF-CA on post-CA days 1 (37% ± 18% vs 14% ± 7% deficit] and 2 [19% ± 12% vs 5% ± 3%], ( Fig. 2A) (p < 0.05). Rats undergoing A-CA retained less day 8 cue-mediated freezing compared with VF-CA Figure 1 . Ventricular fibrillation cardiac arrest (VF-CA) produces greater early postresuscitation cardiogenic shock compared with asphyxial cardiac arrest (A-CA). Sequential measurements of physiologic and biochemical variables reflecting hemodynamics and perfusion were made at baseline (BL) and after defined times (in min) after return of spontaneous circulation (RO; e.g., RO5 = 5 min after RO). VF-CA (red circles; n = 10) resulted in significantly lower cardiac output (A), greater lactate (B), and lower pH (C) compared with A-CA (green squares; n = 10). Heart rate (D) was significantly more depressed after VF-CA than A-CA, and an early reduction in mean arterial pressure (E) was noted at RO5. A-CA resulted in greater hypercarbia than VF-CA (F). *p < 0.05, **p < 0.01, ***p < 0.001. CA = cardiac arrest.
Critical Care Medicine www.ccmjournal.org e511 (Fig. 2B) (p = 0.03). Brain histology revealed greater neuronal loss within several brain regions (CA1, CA2, and cerebellar cortex) after A-CA versus VF-CA ( Table 1) . Day 8 hippocampal degeneration was noted in 75% ± 14% of CA1 neurons after A-CA versus 35% ± 24% after VF-CA (Supplemental 
Mechanism of Increased Brain Injury After A-CA
We found similar mitochondrial dysfunction in heart and brain (p = 0.19) 15 minutes post ROSC independent of CA etiology ( Supplemental Fig. 4 , Supplement Digital Content 6, http://links.lww.com/CCM/D389; legend, Supplemental Digital Content 7, http://links.lww.com/CCM/D390). State 3 oxygen consumption was likewise similar between groups (data not shown). Brain ascorbate (Fig. 3A) and total antioxidant reserve (Fig. 3B) were significantly depleted compared with sham with greater reductions after A-CA versus VF-CA.
Differences in Brain Versus Heart Injury
After Human CA We examined whether our animal findings were recapitulated in the clinical scenario. Of 1,007 patients with etiology assigned, 254 (25%) had cardiac etiology (VF-CA), whereas 286 (28%) had asphyxial etiology (A-CA). VF-CA consisted of acute coronary syndrome (n = 134), primary arrhythmia (n = 5), secondary arrhythmia (n = 60), structural heart disease (n = 7), and left (n = 12) and right (n = 36) ventricular failure. A-CA consisted of drug-induced asphyxia (n = 85), airway obstruction (n = 53), and respiratory decompensation (n = 148). Patients with VF-CA were older and more likely to present with a shockable rhythm (Supplemental Table 2 , Supplement Digital Content 3, http://links.lww.com/CCM/D386). A-CA patients were more likely to be hypercapneic and to exhibit severe hypoxemia.
Patients with VF-CA had less neurologic injury within 6 hours of ROSC (PCAC) and better survival to hospital discharge (58% vs 42%; p < 0.001) ( Table 2) . VF-CA was associated with better functional survival based on discharge disposition (44% vs 18%; p < 0.001). VF-CA was associated with increased myocardial dysfunction versus A-CA based on a lower median LVEF (20%; n = 206 vs 55%; n = 157) and higher median peak troponin I (7.8 vs 0.3 ng/mL). After adjustment, VF-CA was associated with less severe initial brain injury (PCAC IV; odds ratio [ In total, 294 of 540 patients with VF-CA or A-CA died in hospital. We excluded 68 cases where cause of death was multisystem, due to preexisting wishes or comorbidities. Cardiovascular causes accounted for 70 of 226 of the remaining deaths (31%), whereas neurologic injury accounted for 156 of 226 (69%). Cause of death differed based on CA etiology (p < 0.0001) with neurologic death more common after A-CA (117/156; 75%) and cardiovascular death more common after VF-CA (38/70; 54%).
DISCUSSION
This is the first report employing animal modeling of CA coupled with clinical data to elucidate the relationship between CA etiology, end-organ injury, and cause of death. Using translational methods, we observe a consistent picture wherein VF-CA results in greater myocardial injury, whereas A-CA results in greater neurologic injury. In rat models with identical no flow times, VF-CA produced worsened myocardial dysfunction (lower CO) and greater cardiogenic shock (lactic acidosis) than A-CA. Despite worsened shock, VF-CA resulted in better neurologic outcomes than A-CA (NDS, fear conditioning, histology). A-CA is associated with greater consumption of brain antioxidant defenses implying an oxidative injury mechanism. Human data recapitulate these findings: VF-CA is associated with increased cardiac injury (LVEF, troponin) versus A-CA, which is associated with worse neurologic injury (PCAC, disposition). In-hospital death is known to result from brain, followed by heart, injury (34) , and our study demonstrates that etiology predicts injury, which predict mode of death. Thus, etiology is of great clinical significance, and understanding the mechanistic and physiologic differences that result from etiology is needed to target therapies and improve outcomes. This is particularly poignant now as the rising heroin epidemic drives the rising frequency of asphyxia etiology CA (11).
Vaagenes et al (17) showed increases in histologic brain injury after 7 minutes A-CA (13 min total asphyxia) compared with 10 minutes VF-CA in dogs. Despite shorter no flow time, A-CA increased brain injury. Kamohara et al (14) found greater impairment of myocardial function during 240 minutes following ROSC after rat VF-CA versus A-CA of "longer" no flow time. Vaagenes et al (17) and Kamohara et al (14) reported longer CPR times to achieve ROSC after VF-CA versus A-CA. Our findings are consistent with these studies and demonstrate that etiology determines organ injury. The data by Gazmuri et al (35) from isolated rat hearts suggest that VF leads to ischemic contracture with increasing coronary vascular resistance, which may explain its increased impact on CO. Contradictory results (15) within a pig model show greater myocardial dysfunction, cellular injury, and reduced ROSC after A-CA. These disparate findings may reflect species or methodologic differences underscoring the need for clinical correlation.
Appreciating heart versus brain injury based on etiology may have clinical implications. Prior to an A-CA, arterial oxygenation decreases with increasing hypercapnia, whereas in VF-CA, oxygenation is usually normal at CA onset. Furthermore, preexisting comorbidity will also show an impact on outcome (e.g., chronic obstructive pulmonary disease patients vs young patients with drug overdose as a cause of A-CA). Prehospital cooling with IV fluids resulted in a higher frequency of pulmonary edema and recurrent CA (36) . The hypothesis that VF increased cardiac injury explaining these adverse effects is intriguing though speculative. Myocardial dysfunction after CA has been attributed to calcium overload (37) , which parallels classic findings in myocardial infarction (38) . This mechanism may explain why Vaagenes et al (17) found that lidoflazine therapy, a calcium antagonist, improved outcomes after VF-CA but not A-CA and free radical scavengers improved outcomes after A-CA not VF-CA. "Defining CA injury phenotypes based on etiology may be an important step in targeting therapy to optimize outcomes."
Despite greater cardiovascular dysfunction, neurologic outcome in rats and humans are better after VF-CA. This is consistent with early neurologic injury differences, measured by NDS, in VF-CA versus A-CA studies on pigs (39) although not corroborated in the setting of a longer no flow time in rats (14) . Brief global ischemia may increase brain more than heart injury consistent with the findings by Kloner and Jennings (40) that cardiomyocyte death does not occur until greater than 15 minutes ischemia (41) accounting for minimal myocardial apoptosis after rat CA. Most (> 90%) patients with good neurologic outcome achieve ROSC within 16 minutes (42), but ROSC rates remain high (> 10%) even after 20 minutes of CPR (43) suggesting that the brain is more susceptible to prolonged ischemia than the heart. Our primary mechanistic hypothesis was that mitochondrial dysfunction would parallel organ injury, but this was not confirmed. Prior studies have reported greater cardiac (15, 44) mitochondrial dysfunction after A-CA compared with VF, but neither achieved ROSC thus limiting reperfusion injury. We next measured antioxidant reserve in brain, as injury from reactive oxygen species (ROS) represents an early pathway to brain injury (45) (46) (47) . We found greater reductions in antioxidant reserve after A-CA implying that this etiology increases neurologic injury. This mechanistic hypothesis requires further confirmation.
A strength of our study is our attempt to clinically correlate our findings. Using a high-resolution CA database where etiology and cause of death are expertly assigned, we examined whether our rat results translated to humans. We corroborated that VF-CA causes more severe myocardial dysfunction (troponin and LVEF) which is clinically significant as it results in death due to hemodynamic instability. Since VF-CA had reduced neurologic injury (PCAC), in-hospital mortality and long-term functional impairment were less than A-CA where brain injury is more severe.
Our study naturally has limitations, but we have attempted to use animal and clinical data in a complementary way to buttress these. Prehospital estimates of no/ low flow times have poor reliability within our database and were not adjusted for (48) , but our rat models permit precise ischemic time matching. Our rats were young, healthy males; hence, our clinical findings are important to show these animal results are more generalizable and free of gender specificity. VF rats required more epinephrine to achieve ROSC which we infer is the result of greater myocardial dysfunction, but we cannot exclude negative effects of epinephrine on the heart. The corroborating human data are reassuring. The differences noted in ROS injury which presumably originate from mitochondria (45) may have resulted in delayed mitochondrial dysfunction, yet we only examined an early time. We matched no flow CA time rather than total insult time (asphyxia); however, others recapitulated our findings using different matching strategies (14, 17) . Only 28% of the A-CA patients received a recorded echocardiogram within 48 hours of ROSC. These patients were presumably a biased subset with hemodynamic problems, yet their LVEF remained better than VF-CA. Rat VF was induced electrically, which could
